Chinook Therapeutics, Inc.
1600 Fairview Avenue East, Suite 100
Seattle, WA 98102
April 12, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: | Dillon Hagius | |
| Re: | Chinook Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-255099) Filed April 7, 2021 | |
Requested Date: April 14, 2021
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Chinook Therapeutics, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Amanda Rose or Ryan Mitteness, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Amanda Rose at (206) 389-4553 or in her absence, Ryan Mitteness at (206) 389-4533.
| Sincerely, | ||
| CHINOOK THERAPEUTICS, INC. | ||
| By: | /s/ Eric Dobmeier | |
| NAME: | Eric Dobmeier | |
| TITLE: | President and Chief Executive Officer | |
| cc: | Amanda Rose |
Ryan Mitteness
Fenwick & West LLP
[Signature Page to Acceleration Request Letter]
